We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

January 31, 2011

Justin Mui v. Mannkind Corporation et al - THE MANNKIND SECURITIES ACTIONS

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 10, 2012

    MannKind To Pay $23M In Investor Suit Over Diabetes Drug

    A California judge on Monday preliminarily approved MannKind Corp.'s $23 million securities class action settlement with shareholders who claim the pharmaceutical company misled them about the regulatory approval prospects of its diabetes drug Afrezza, allegedly causing up to $158 million in investor losses.


Parties

To view the parties, register now.